ETON
No price yet
Announcements
Nothing here yet
Daily updates
Nothing here yet
FDA designations
Nothing here yet
News
- Eton Pharmaceuticals announces U.S. commercial availability of IMPAVIDO (miltefosine) capsulesSep 28, 2026
- Eton Pharmaceuticals expanded its infantile hemangioma portfolio by acquiring U.S. rights to late-stage candidate ASN-001Aug 6, 2026
- Eton Pharmaceuticals submits prior approval supplement to expand KHINDIVI oral solution indicationJul 29, 2026
- Eton Pharmaceuticals expands rare disease portfolio through U.S. commercialization agreement for IMPAVIDOMay 20, 2026
- Eton Pharmaceuticals expanded its rare disease portfolio by acquiring U.S. commercialization rights to HEMANGEOL® oral solutionMar 2, 2026